Drugs, patents and policy: a contextual study of Hong Kong

In pharmaceutical patent law, the problem of lack of policy direction and inappropriate legal framework is widespread - particularly among jurisdictions with little to no pharmaceutical research or manufacturing.

This book aims to inform public policy and influence debate through a comprehensive review of Hong Kong's pharmaceutical patent law.

By demonstrating the need for a holistic review of pharmaceutical patent laws and evaluating Hong Kong's system in light of health policy, economic and social factors, Bryan Mercurio recommends changes to the legal framework and constructs a more efficient and effective system for Hong Kong.

He thoroughly evaluates the international framework and best practice models to offer a global perspective to each issue before providing local context in the analysis.